NCT04082975View on ClinicalTrials.gov

Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain

PHASE3CompletedINTERVENTIONAL

Enrollment

421

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

May 24, 2021

Study Completion Date

May 31, 2021

Conditions

Acute Low Back Pain

Interventions

DRUG

NVP-1203

Oral dose for 7 days

DRUG

NVP-1203-R

Oral dose for 7 days

DRUG

NVP-1203 placebo

Oral dose for 7 days

DRUG

NVP-1203-R placebo

Oral dose for 7 days

Trial Locations (1)

16209

Navipharm, Suwon

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NVP Healthcare

INDUSTRY